Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Author： Yardley Denise Hart Lowell Waterhouse David Whorf Robert Drosick D. Murphy Patrick Badarinath Suprith Daniel Brooke Childs Barrett Burris Howard

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.3, 2013-12, pp. : 655-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: As Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer

By Wiseman Lynda R. Keam Susan J.

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 199-206

Adis International

Access to resources Recommend Favorite

New Clinical Trends in the Adjuvant Therapy of Early Stage Breast Cancer

By Singletary S. Eva

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 411-419

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens

By Cocconi G.

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Therapy in Elderly Patients with Early Breast Cancer

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 315-325

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel as Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer: A Viewpoint by Steven D. Heys and Nicole J. McCarthy

By Heys Steven D.

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 207-209

Adis International

Access to resources Recommend Favorite